Literature DB >> 1211406

Acute bacterial meningitis: an analysis of factors influencing prognosis.

G R Hodges, R L Perkins.   

Abstract

Three-hundred and forty-nine cases of acute bacterial meningitis treated during a 25-year period (1949 through 1973) were reviewed to determine the prognostic significance of initial historical, physical and laboratory findings. A poor prognosis was associated with age greater than or equal to 40 years (p less than 0.01), presence of predisposing illness (p less than 0.01), associated illness (p less than 0.01), absence of nuchal ridity (p less than 0.05), and derangement of cerebral function (p less than 0.01). The effects of predisposing illness and moderate cerebral dysfunction were dependent upon age. In contrast, the effects of associated illness, mild or severe cerebral dysfunction, and absent nuchal rigidity were independent of age. Laboratory studies associated with a poor prognosis included an elevated cerebrospinal fluid (CSF) protein (p less than 0.05), a positive CSF smear (p less than 0.05), or culture (p less than 0.01), or bacteremia (p less than 0.01). No prognostic significance could be attributed to race (p greater than 0.05), sex (p greater than 0.05), prior antibiotic therapy (p greater than 0.05), duration of illness before institution of adequate therapy (p greater than 0.05), CSF leukocyte count (p greater than 0.05), frequency of polymorphonuclear leukocytes in CSF (p greater than 0.05), CSF sugar less than or equal to 40 mg/100 ml (p greater than 0.05), or a CSF sugar-simultaneous blood sugar ratio less than or equal to 0.40 (p greater than 0.05).

Entities:  

Mesh:

Year:  1975        PMID: 1211406     DOI: 10.1097/00000441-197511000-00003

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  16 in total

1.  Experimental pneumococcal meningitis causes central nervous system pathology without inducing the 72-kd heat shock protein.

Authors:  M G Täuber; S L Kennedy; J H Tureen; D H Lowenstein
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

Review 2.  Current concepts in bacterial meningitis.

Authors:  S M Hahn
Journal:  West J Med       Date:  1989-08

3.  Influence of antibiotic dose, dosing interval, and duration of therapy on outcome in experimental pneumococcal meningitis in rabbits.

Authors:  M G Täuber; S Kunz; O Zak; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

4.  Artificial ventilation and prognostic factors in bacterial meningitis.

Authors:  N Rasmussen; B Hansen; V Bohr; H S Kristensen
Journal:  Infection       Date:  1988 May-Jun       Impact factor: 3.553

5.  Possible predictive parameters for the outcome of bacterial meningitis.

Authors:  G Ventura; M B Lucia; G Scoppettuolo; M Tumbarello; R Cauda
Journal:  Ital J Neurol Sci       Date:  1994-11

6.  Prognostic value of cytobiochemical changes in children with pyogenic meningitis.

Authors:  R H Udani; A G Desai; R B Patel; P G Samdani; S Chothani
Journal:  Indian J Pediatr       Date:  1983 Sep-Oct       Impact factor: 1.967

7.  Attenuation of the bacterial load in blood by pretreatment with granulocyte-colony-stimulating factor protects rats from fatal outcome and brain damage during Streptococcus pneumoniae meningitis.

Authors:  Christian T Brandt; Jens D Lundgren; Søren Peter Lund; Niels Frimodt-Møller; Thomas Christensen; Thomas Benfield; Frank Espersen; David M Hougaard; Christian Østergaard
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

8.  Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits.

Authors:  W M Scheld; M A Sande
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

9.  Bacterial meningitis in Nottingham.

Authors:  P Ispahani
Journal:  J Hyg (Lond)       Date:  1983-10

10.  Bacterial meningitis--ten years experience.

Authors:  P G Davey; J K Cruikshank; I C McManus; B Mahood; M H Snow; A M Geddes
Journal:  J Hyg (Lond)       Date:  1982-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.